2022³â
ÁÖ¿ä È°µ¿³»¿ë |
¾àÁ¦½Ç ´º½º·¹ÅÍ ¹ßÇà(2¿ù, 4¿ù, 6¿ù, 8¿ù, 10¿ù, 12¿ù, ÃÑ 6Â÷·Ê) |
---|---|
ÁÖ»ç¾àÇ°ÀÇ ±Ý±â Åõ¿©°æ·Î ó¹æ Á¦ÇÑ(2022.02) | |
»êÁ¦Ã³¹æ ½Ã, ºÒ°¡¾àÇ°ÀÇ ´ëü¾àÇ° ¹× ´ë¾ÈÁ¤º¸ Æ˾÷ Á¦°ø(2022.10) | |
Ç×»ýÁ¦ skin test Áöħ °³Á¤(2023.01) - ¼¼ÆÄ°è Ç×»ýÁ¦ ¹Ì½ÃÇà, ÃÊÁø ±â·Ï ½Ã Ç×»ýÁ¦ °ú¹Î¹ÝÀÀ °ú°Å·Â Á¶»ç ½Ç½Ã, °Ë»ç ½ÃÇà ¹æ¹ý °³Á¤ |
|
¾à¹« ¾÷¹« DW ±¸Ãà(2022.12) | |
¡®PRN ½Ç½Ã ±âÁØ Çʼö Ç׸ñ ±âÀçÀ²¡¯ ÁöÇ¥ °ü¸® ¹× PRN Áߺ¹ ó¹æ °³¼± È°µ¿ | |
ÀÀ±ÞÀÇ·á¼¾ÅÍ Åð¿ø¾à º¹¾àÁöµµ ½Ç½Ã(2022. 08) | |
¾àÁ¦½Ç µµ±Þ¾÷ü(¾àÇ°¹è¼Û, ÅÁÀü½Ç) °è¾à ÀÔÂû ¹× °è¾à(2022.02) | |
Çѹ溴µ¿ ÀÔ¿øȯÀÚ ÅÁ¾à ÀÏ¿äÀÏ, °øÈÞÀÏ ¹è¼Û Ãà¼Ò(2022.10) | |
¼ö»ó | ±èÁ¤Å : [½Ä¾àó, º¹ÁöºÎ ÁÖÃÖ ¾àÀdz¯ ±â³ä½Ä] ±¹¹«ÃѸ® ǥâ(2022.11.18) |
±èÁ¤º¸ : [¿ø³» ǥâ] ȯÀÚ¾ÈÀü°ü¸® ¿ì¼öÁ÷¿ø(2022.09.14) | |
¹ßÇ¥ | Àüº¸¶÷, À±ÁöÀº, ÀÌÇöÁ¤, ¿¹°æ³², ±èÁ¤Å : [Poster] À¯ÀüÀÚÄ¡·áÁ¦ ÀÓ»ó½ÃÇè °ü¸®¾à»çÀÇ ¾÷¹«(2022.06.16) |
¿¹°æ³², ÀÌÇöÁ¤, ±èÁ¤º¸, ±èÁ¤Å : [Poster] ¼¼ÆķνºÆ÷¸°°è Ç×»ýÁ¦ skin test ÇöȲ Á¶»ç¸¦ ÅëÇÑ ¿ø³» Áöħ °³Á¤ ±âÃÊÀÚ·á Á¦¾È(2022.11.19) | |
À±Áö¿µ, ±èÁ¤º¸, ±èÁ¤Å : [Poster] ÁßȯÀÚ½Ç Àü´ã ¾à»çÀÇ Ã³¹æ ÁßÀç ÇöȲ ºÐ¼®(2022.11.19) | |
Àå¹Ì¾Ö, À±ÁöÀº, ¿¹°æ³², ±èÁ¤Å : [Poster] Atezolizumab ¾à¹° »ç¿ë Æò°¡(2022.11.19) | |
¿¬±¸ ³í¹® | Jimin Yoon, Ji Seob Yug, Dae Yun Ki, Ji-Eun Yoon, Sung Wook Kang, Eun Kyoung Chung : Characterization of Medication Errors in a Medical Intensive Care Unit of a University Teaching Hospital in South Korea, Journal of Patient Safety, Volume 18(1):p 1-8(2022.01.01) |
Kyong Nam Ye, Young Ju Cheon : The Incidence of Adverse Drug Reaction Spontaneously Reported in a General Hospital, J. Kor. Soc. Health-syst. Pharm, Vol. 39, No. 1, 29 ~ 39 (2022.02.28) | |
¹ÚÈ¿Á¤, ¿À»óÇö, ±èÁ¤ÅÂ, ¼º¿¹¿ø, ³²ÀçÇö, ¹èÇýÁ¤, Á¤Àç¹Î, ±è¼±È, Á¤ÁöÀº : Çѱ¹ÀÇ ÁýÁß¿µ¾çÄ¡·á·á¿Í ÁÖ»çÁ¦ ¹«±ÕÁ¶Á¦·á- °í¿µ¾ç¼ö¾×Á¦ ÇöȲ Á¶»ç: 2014~2020, º´¿ø¾à»çȸÁö, Vol. 39, No. 1, 69 ~ 80(2022.02.28) | |
KyungwonYoon, Jung-Tae Kim, Won-Gun Kwack, DonghyunKim, Kyung-Tae Lee, SeungwonYang, SangminLee, Yeo-JinChoi, Eun-KyoungChung : Potentially Inappropriate Medication Use in Patients with Dementia, Int. J. Environ. Res. Public Health, Volume 18(1):p 1-8(2022.09.10) |
2021³â
ÁÖ¿ä È°µ¿³»¿ë |
¾àÁ¦½Ç ´º½º·¹ÅÍ ¹ßÇà(2¿ù, 4¿ù, 6¿ù, 8¿ù, 10¿ù, 12¿ù, ÃÑ 6Â÷·Ê) |
---|---|
Äڷγª 19 ¹é½Å ¿¹¹æÁ¢Á¾¼¾ÅÍ ³» ¹é½Å °ü¸® | |
FMEA¸¦ ÅëÇÑ Á¶Á¦¿À·ù °¨¼ÒÈ°µ¿ | |
ÇѹæÁ¶Á¦ÆÄÆ® Á÷¿ø ´ë»ó ÇѾàó¹æ ÇÁ·Î¼¼½º °³¼± È°µ¿ (2021.05) | |
´À·ç¿ä¾çº´¿ø ¿ø¿ÜÅÁÀü½Ç(¿ëÀÎ, Áø¾È)Çù¾àÀ¸·Î ¿¬Á¶¿¢½ºÁ¦(È«»ïÃѸíÅÁA ¿Ü 7Á¾) µµÀÔ(2021.05) | |
¼ö»ó | ÀÌÇöÁ¤, ±è¼ÛÀÌ, ¿¹°æ³², ±èÁ¤Å : Çѱ¹º´¿ø¾à»çȸ ¿ì¼ö Æ÷½ºÅÍ»ó |
Á¶Á¦ÆÀ : [¿ø³» ǥâ] ȯÀÚ¾ÈÀü°ü¸® ÃÖ¿ì¼öºÎ¼ ǥâ | |
¹Ú¹Ì¼±, ÀÌÇöÁ¤, ¿¹°æ³², ±èÁ¤Å : Çѱ¹º´¿ø¾à»çȸ ¿ì¼ö Æ÷½ºÅÍ»ó | |
¿¹°æ³², ÀÌÇöÁ¤, ±èÁ¤Å : [¿ø³» KPI Æ佺Ƽ¹ú] ÃÖ¿ì¼ö»ó ¼ö»ó | |
±èÁ¤º¸, À±Áö¿µ, ÇѾƶ÷ : [¿ø³» KPI Æ佺Ƽ¹ú] Àå·Á»ó ¼ö»ó | |
¹ßÇ¥ | ÀÌÇöÁ¤, ±è¼ÛÀÌ, ¿¹°æ³², ±èÁ¤Å : [Poster] Ç×»ýÁ¦ ÇǺιÝÀÀ½ÃÇè ó¹æ ¹× °á°ú ÀÔ·Â ¹æ¹ý °³¼± È°µ¿, Çѱ¹º´¿ø¾à»çȸ Ãá°èÇмú´ëȸ |
¹Ú¹Ì¼±, ÀÌÇöÁ¤, ¿¹°æ³², ±èÁ¤Å : [Poster] ´ÜÀϱâ°ü¿¡ º¸°íµÈ COVID-19 ¹é½Å ¾à¹° ÀÌ»ó¹ÝÀÀ º¸°í ÇöȲ ºÐ¼®, Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ | |
ÇѾƶ÷, À±Áö¿µ, ±èÁ¤º¸, ±èÁ¤Å : [Poster] FMEA¸¦ ÅëÇÑ Á¶Á¦¿À·ù ¿¹¹æÈ°µ¿ È¿°ú, Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ | |
¿¬±¸ ³í¹® | Kyung im Kim, Jin young Jung, Hae sook Kim, Jung Tae Kim, Jung Mi Oh, Hyun Ah Kim : Potentially Inappropriate Prescriptions to Older Patients in Emergency Departments in South Korea : A Retrospective Study, Therapeutics and Clinical Risk Management, Vol. 2021:17, 173~181, May 20, 2021 |
2020³â
ÁÖ¿ä È°µ¿³»¿ë |
¾àÁ¦½Ç ´º½º·¹ÅÍ ¹ßÇà(2¿ù, 4¿ù, 6¿ù, 8¿ù, 10¿ù, 12¿ù, ÃÑ 6Â÷·Ê) |
---|---|
ÀÓ»ó¾à °ü¸® Àü´ã °è¾àÁ÷ ¾à»ç ÀüÀÏÁ¦ º¯°æ (2020.03~) | |
¿ø¿Ü¾à±¹ °£´ãȸ (2020.03) | |
Åð¿ø¾à Åõ¾à ¿À·ù FMEA È°µ¿ | |
Ç÷¿ìº´ ¾àÇ°ÀÇ ¹ÙÄÚµå ½Ã½ºÅÛ µµÀÔÀ» ÅëÇÑ ¾ÈÀü°ü¸® ±¸Ãà (2020.03) | |
¿ø¿ÜÅÁÀü½Ç ¾àħÁ¦Á¦ µµÀÔ (2020.03) | |
ÇÑ¾à °ü¸® ÇÁ·Î¼¼½º °³¼±À» ÅëÇÑ ÇѾà Æó±âÀ² °¨¼Ò È°µ¿ (2020.05) | |
¼ö»ó | À̹ΰæ, ¿¹°æ³², ±èÁ¤Å : Çѱ¹º´¿ø¾à»çȸ ÇмúÀå·Á»ó |
±èÁ¤º¸, ÀÌÇöÁ¤, ¿¹°æ³², ±èÁ¤Å : Çѱ¹º´¿ø¾à»çȸ ¿ì¼ö Æ÷½ºÅÍ»ó | |
¾à¹«ÆÀ : [¿ø³» ǥâ] ȯÀÚ¾ÈÀü°ü¸® ÃÖ¿ì¼öºÎ¼ ǥâ | |
¿¹°æ³², ÀÌÇöÁ¤, ±èÁ¤Å : [¿ø³» KPI Æ佺Ƽ¹ú] ÃÖ¿ì¼ö»ó ¼ö»ó | |
¹ßÇ¥ | ±èÁ¤º¸, ÀÌÇöÁ¤, ¿¹°æ³², ±èÁ¤Å : [Poster] Ç÷¿ìº´ ¾àÇ°ÀÇ ¹ÙÄÚµå ½Ã½ºÅÛ µµÀÔÀ» ÅëÇÑ ¾ÈÀü°ü¸® ±¸Ãà |
¿¬±¸ ³í¹® | Hyo Jung Park, Jung Tae Kim, Jee Eun Chung, Jin A. Yang, Hye Jung Bae, Ye Won Sung, Ji Eun Park, Sun Hwa Kim, Ji Yoon Cho, Kyung Mi Jung, Hee Kyung Bae : Practice of parenteral nutrition in hospitalized adult patients in Korea: A retrospective multicenter cross-sectional study, PLoS ONE, 15(4): e0230922, April 1, 2020 |
¹ÚÈ¿Á¤, ¼ÕÀ¯¹Î, Á¤ÁöÀº, ±èÁ¤ÅÂ, ¾çÁø¾Æ, ¹èÇýÁ¤, ¼º¿¹¿ø, ±è¼±È, Á¶ÁöÀ±, Á¤°æ¹Ì, ¹èÈñ°æ : ±¹³» ÀÔ¿øÇÑ ¼ºÀÎ ¾ÏȯÀÚÀÇ Á¤¸Æ¿µ¾ç »ç¿ë¿¡ ´ëÇÑ ÈÄÇâÀû ¿¬±¸, J Clin Nutr, Vol. 12, No. 2, 34~40, Dec 15, 2020 | |
Jung Tae Kim, Jeong Yun Park, Hyun Jung Lee, Young Ju Cheon : Guidelines for the management of extravasation, J Educ Eval Health Prof, 2020; 17: 21, Aug 10, 2020 | |
À̹ΰæ, ¿¹°æ³², ±èÁ¤Å : Nivolumab, PembrolizumabÀÇ ÀÓ»óÀû »ç¿ë ÀûÁ¤¼º, À¯È¿¼º ¹× ¾ÈÀü¼º Æò°¡, º´¿ø¾à»çȸÁö, Vol. 37, No. 2, 178 ~ 189, Apr 13, 2020 |
2019³â
ÁÖ¿ä È°µ¿³»¿ë |
¾àÁ¦½Ç ´º½º·¹ÅÍ ¹ßÇà(2¿ù, 4¿ù, 6¿ù, 8¿ù, 10¿ù, 12¿ù 6Â÷·Ê) |
---|---|
ÀÓ»ó¾à °ü¸® Àü´ã ¹ÝÀÏ °è¾àÁ÷ ¾à»ç ä¿ë(2019.09 ~ ) | |
ÁÖ»çÁ¦ ó¹æÁ¡°ËÀ» À§ÇÑ IV compatibility ÇÁ·Î±×·¥ Àû¿ë ¹× ¸ð´ÏÅ͸µ | |
º´¿øº° ¿¹·°á»êºÐ¸®¹æħ¿¡ µû¸¥ ERP ¾à¹«ÇÁ·Î±×·¥ ¼öÁ¤ | |
¾àÇ°Ãâ°íÇöȲ ÀÌ·Â ¹× ¾àǰó¹æÇöȲ ÀÌ·Â Á¶È¸¸¦ À§ÇÑ DW ±¸Ãà | |
ÀϷùøÈ£Á¦µµ ±â¹Ý ¾àÇ° À¯È¿±â°£ °ü¸®È¸é °³¹ß ¹× Àû¿ë | |
ÀÇ·á±â°ü Á¶Á¦½ÇÁ¦Á¦ ÀçÁ¤ºñ(2019.04) | |
¹«±ÕÁ¶Á¦½Ç °ø»ç(2019.06) ¹× »ý¹°¾ÈÀüÀÛ¾÷´ë(BSC) ±³Ã¼(2019.07) | |
Åð¿ø¾à º¹¾àÁöµµ È®´ë (8A, 8B º´µ¿) (2019.06) | |
¿Ü·¡ ÇѾàÁ¦Á¦ ȯÀÚ Åõ¾à¿ë ¶óº§ ±ÇÀå º¹¿ë±â°£ Ç¥±â (2019.11) | |
¿Ü·¡È¯ÀÚ ÅÁ¾à Æ÷Àå °³º° ¶óº§¸µ È®´ë (2019.11) | |
°µ¿±¸ º¸°Ç¼Ò ÀÇ·Ú ÀǾàÇ°¾ÈÀü »ç¿ë ±³À° ¼öÇà (2019.03 ~ 09) | |
DUR °íµµÈ ½Ã¹ü »ç¾÷ Âü¿© (2019.08 ~ 12) | |
Á¦21ȸ º´¿ø¾àÇבּ¸°úÁ¦ ¿¬±¸ ¼öÇà | |
¼ö»ó | À̹ΰæ, ¿¹°æ³², ±èÁ¤Å : Çѱ¹º´¿ø¾à»çȸ ¿ì¼ö Æ÷½ºÅÍ»ó |
QI È°µ¿ | Ç÷¿ì¾àÀÇ Á¤È®ÇÑ Á¶Á¦ ¹× ºÒÃâÀ» À§ÇÑ ¹ÙÄÚµå ½Ã½ºÅÛ µµÀÔ |
¹ßÇ¥ | Jong Pil Won, Young Ju Cheon, Min Kyung Lee, Jung Bo Kim, Kyong Ju Jeong, Jung Tae Kim : [Poster] Improvement of Pharmacists¡¯ Interventions Using SBAR Communication Tool, 2019³â Á¦29ȸ ÀϺ» ÀÇ·á¾àÇÐȸ(JSPHCS) ¿¬È¸ |
À̹ΰæ, ¿¹°æ³², ±èÁ¤Å : [Poster] Nivolumab, PembrolizumabÀÇ ÀÓ»óÀû »ç¿ë ÀûÁ¤¼º, À¯È¿¼º ¹× ¾ÈÀü¼º Æò°¡, Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ | |
À±Áö¿µ, ¿¹°æ³², ±èÁ¤Å : [Poster] High-dose buprenorphine patch ¾à¹° »ç¿ë ÀûÁ¤¼º Æò°¡, Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ | |
¿¹°æ³², õ¿µÁÖ, ±èÁ¤º¸, ±èÁ¤Å : [Poster] ±¹³» º´¿øÀÇ ÁÖ»çÁ¦ ó¹æ°¨»ç ½Ã½ºÅÛ ±¸Ãà ÇöȲ Á¶»ç, Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ | |
¿¬±¸ ³í¹® | ¿øÁ¾ÇÊ, õ¿µÁÖ, À̹ΰæ, ±èÁ¤º¸, Á¤°æÁÖ, ±èÁ¤Å : SBAR µµ±¸¸¦ ÀÌ¿ëÇÑ Ã³¹æÁßÀç ¾÷¹« °³¼±, º´¿ø¾à»çȸÁö 36(2) 261-271, 2019 |
õ¿µÁÖ, ¿¹°æ³², ¼ÛÇضõ, ±èÅÂ, ¹ÚÁø°æ, ±èÁ¤ÅÂ, ÀÓ¼º½Ç : Á¤½Å°ú ¿Ü·¡ ȯÀÚÀÇ »ö伱ȣµµ¿Í ÁßÃ߽Űæ°è ¾à¹°Ä¡·á ȯÀÚµéÀÇ º¹¾à¼øÀÀµµ¿¡ °üÇÑ ±âÃÊ¿¬±¸, ´ëÇѾàÇÐȸÁö 63(4) 221-229, 2019 | |
Hyun-moon Back, Jong Bong Lee, Nayoung Han, Sungwoo Goo, Eben Jung , Junyeong Kim , Byungjeong Song , Sook Hee An , Jung Tae Kim , Sandy Jeong Rhie , Yoon Sun Ree , Jung-woo Chae , JaeWoo Kim, Hwi-yeol Yun : Application of Size and Maturation Functions to Population Pharmacokinetic Modeling of Pediatric Patients, Pharmaceutics Vol. 11, Issue 6, 259, 2019 | |
¼³Àº¹Ì, ±Ç°è¼÷, ±èÁ¤±¸, ±èÁ¤ÅÂ, ±èÁöÈÆ, ¹®¼±¹Ì, ¹ÚµµÁß, ¹ÚÁ¤Çö, ¹ÚÁ¦ÈÆ, ¹ÚÁö¿µ, ¹èÁ¤¹Î, ·ù½Â¿Ï, ¼³Áö¿µ, ½Åµ¿¿ì, ½ÅÁõ¼ö, ¾Èº´±Ô, ¾È¼ö¹Î, À¯Èñö, À̱æÀç, ÀÌ»óÈÆ, À̾ƶõ, ÀåÀ翵, ÀüÇöÁ¤, Á¤¼º¹Î, ÇѼº½Ä, È«¼®°æ, Ȳ¼øÈÖ, ÃÖÀ±Èñ, ÀÌÇõÁØ : ¼ºÀÎ ÀÔ¿ø ȯÀÚ¿¡¼ÀÇ ¿µ¾çÄ¡·á °ü·Ã ÇÕº´Áõ: ±¹³» ´Ù±â°ü ¿¬±¸, J Clin Nutr Vol. 11, No. 1, 12~22, 2019 |
2018³â
ÁÖ¿ä È°µ¿³»¿ë |
Ư¼öÁ¶Á¦ÆÄÆ® ½Å»ý¾ÆÁßȯÀÚ½Ç ¸®Çǵå ÁÖ»ç ¹«±Õ Á¶Á¦(2018.01.02.~) |
---|---|
ÁßȯÀÚ½Ç ´ÙÇÐÁ¦ÆÀ ȸÁø ½ÃÀÛ (2018.05) | |
¸¶¾à·ùÅëÇÕ°ü¸®½Ã½ºÅÛ ½ÃÇàÀ» À§ÇÑ EMR ¿¬°è ÇÁ·Î±×·¥ °³¹ß ¹× ÇÁ·Î¼¼½º ±¸Ãà (2018.05) | |
ÀÀ±Þ½Ç ÀüÀÚµ¿ ºÐ¹è ijºñ´Ö (ADC) Àåºñ ¿î¿µ (2018.05) | |
ÇѹæÁ¶Á¦ÆÄÆ® - °æÈñ´ëÀÇ·á±â°ü ÅÁÀü½Ç °øµ¿ ÀÌ¿ë °è¾à ü°á (2018.08) | |
¾à¹«ÆÀ-ÀǾàÇ° °ø±Þ¾÷ü °£ ÀÎÅÍÆäÀ̽º ±¸Ãà (2018.10.01.) | |
¼ö»ó | Á¶Á¦ÆÀ: ¿ø³» ȯÀÚ¾ÈÀü°ü¸® ÃÖ¿ì¼öºÎ¼ ǥâ |
¿¹°æ³², Á¤°æÁÖ, ±èÁ¤ÅÂ: Çѱ¹ÀÓ»ó¾àÇÐȸ ¿ì¼öÆ÷½ºÅÍ»ó | |
¿¹°æ³², À±ÁöÀº, Àå¼ö¹Ì, ±èÁ¤ÅÂ: ¿ø³» KPI Æ佺Ƽ¹ú ÃÖ¿ì¼ö»ó | |
QI È°µ¿ | °íÀ§Çè, °íÁÖÀÇ ¾à¹°¿¡ ´ëÇÑÁ¤º¸ Á¦°ø¹æ¹ý °³¼±À» ÅëÇÑ ¾à¹° ¾ÈÀü »ç¿ë Çâ»ó È°µ¿ |
Á¤È®ÇÑ ÀÇ»ç¼ÒÅë È®¸³À» À§ÇÑ SBAR µµ±¸ Àû¿ë ó¹æÁßÀç¾÷¹« °³¼± È°µ¿ | |
¹ßÇ¥ | ¹èÈñ°æ, À±ÁöÀº, ±èÁ¤ÅÂ: [Poster] ¿µ¾çÁýÁßÁö¿øÆÀ(NST) ÀÇ·Ú·Î »ìÆì º» ÀÔ¿øÇÑ ¼ºÀΠȯÀÚÀÇ ¿µ¾çÄ¡·á¿Í °ü·ÃµÈ ÇÕº´Áõ ºÐ¼®, KSHP 2018 Ãß°èÇмú´ëȸ |
À±ÁöÀº, À°Áö¼·, À±Áö¹Î, ±â´ëÀ±, Á¤Àº°æ, °¼º¿í, ¿¹°æ³², ±èÁ¤ÅÂ: [Poster] Á¾ÇÕº´¿ø ³»°úÁßȯÀڽǿ¡¼ ¹ß»ýÇϴ ó¹æ¿À·ù ºÐ¼®, KSHP 2018 Ãß°èÇмú´ëȸ | |
¿¹°æ³², Á¤°æÁÖ, °ÀºÈ¿, °íÀº¾Ö, ±èÁ¤ÅÂ: [Poster] Empagliflozin ¾à¹° »ç¿ë ÀûÁ¤¼º Æò°¡, KSHP 2018 Ãß°èÇмú´ëȸ | |
¿øÁ¾ÇÊ, õ¿µÁÖ, ±èÁ¤º¸, À̹ΰæ, ¹Îº´È£, Á¤°æÁÖ, ±èÁ¤ÅÂ: [Oral] SBAR µµ±¸ È°¿ëÀ» ÅëÇÑ ¾à»çÀÇ Ã³¹æÁßÀç ¾÷¹« °³¼± | |
Kyong Nam Ye, Si Woo Kang, Eun Ae Ko, Jung In Mun, Haeng Eun Jeong, , Kyong Ju Jeong, Jung Tae Kim , Eun Kyoung Chung: [Poster] Comparative Effectiveness and Safety of Empagliflozin vs. Dapagliflozin in Diabetic Patients in Korea, Çѱ¹ÀÓ»ó¾àÇÐȸ 2018 Ãß°èÇмú´ëȸ | |
Kyong Ju Jeong, Kyong Nam Ye, Haemg Eun Jeong, Jung In Mun, Jung Tae Kim: [Poster] Real-world efficacy and safety of dapagliflozin at a single institution in korea, ASHP MCM 2018 | |
Ji Eun Yoon, Ji Seob Yug, Ji Min Yoon, Dae Yun Ki, Eun Kyoung Chung, Sung Wook Kang, Kyong Nam Ye, Jung Tae Kim: [Poster] Analysis of medication errors in ICU in Korea; single center, retrospective, preliminary study, ASHP MCM 2018 | |
¿¬±¸ ³í¹® | ÃÖµ¿¿í, ¿¹°æ³², ±èÁ¤ÅÂ, ¾È¼÷Èñ: ½Å»ý¾ÆÁßȯÀÚÀÇ phenobarbital ¿ë·®°ú Ä¡·á¾à¹°³óµµ¸ð´ÏÅ͸µ; ´ëÇѾàÇÐȸÁö, 62(1) 49-53, 2018 |
2017³â
ÁÖ¿ä È°µ¿³»¿ë |
±¸±Ûµå¶óÀ̺긦 ÀÌ¿ëÇÑ Ç÷¿ì¾àÇ° Àç°í°ü¸® °³½Ã (2017.3¿ù) |
---|---|
°ú·® ¹ß»ý ¸®ÅϾàÇ°(nebulizer)ÀÇ Ã³¹æ ¹× »ç¿ë ÇÁ·Î¼¼½º °³¼± È°µ¿ | |
XCODE ¾àÇ° Áý°è ÇÁ·Î±×·¥ °³¹ß Àû¿ë | |
¾à±¹-ERP ¿¬°è DW ÇǹþÅ×ÀÌºí °³¹ß Àû¿ë | |
ÀÀ±Þ½Ç ÀüÀÚµ¿ ºÐ¹è ijºñ´Ö (ADC) Àåºñ ½Ã¹ü µµÀÔ ¿î¿µ (2017.04.18.) | |
¼ö»ó | ±èÁ¤ÅÂ: Çѱ¹º´¿ø¾à»çȸ Çмúº»»ó |
À̹ΰæ, ±èÁ¤ÅÂ: Çѱ¹ÀÓ»ó¾àÇÐȸ ¿ì¼ö Æ÷½ºÅÍ»ó | |
QI È°µ¿ | ¾àÁ¦½Ç: Pharmacy-SBAR¸¦ ÀÌ¿ëÇÑ Ã³¹æÁßÀç°ü¸® °³¹ß Àû¿ë |
Ư¼öÁ¶Á¦ÆÄÆ®: Ç×¾ÏÁ¦ A to Z ±îÁö ¾Ë·Á µå·Á¿ä! | |
¹ßÇ¥ | Hee Kyung Bae, Jung Tae Kim: [Poster] Drug Utilization Review of gemcitabine plus erlotinib in patients with locally advanced or metastatic pancreatic cancer ACCP 2017 |
õ¿µÁÖ, Á¤°æÁÖ, ±èÁ¤Å : [Poster] ¹ÌÁý°è û±¸¼º¾àÇ°¿¡ ´ëÇÑ ¾àÇ°°ü¸®½Ã½ºÅÛ °³¹ß Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ |
|
À̹ΰæ, ¹èÈñ°æ, ±èÁ¤Å : [Poster] Á¾¾ç ´ã´ç¾à»çÀÇ Ã³¹æÁßÀç ¹× ±³À° ¾÷¹« °³¼±È°µ¿ Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ |
|
¿¬±¸ ³í¹® | õ¿µÁÖ, ¿¹°æ³², ±èÁ¤º¸, Á¤°æÁÖ, ±èÁ¤Å : ±×·ìó¹æ¾àÇ° Áý°è¸¦ ÀÌ¿ëÇÑ ¾àÇ°°ü¸® ¾÷¹« °³¼± º´¿ø¾à»çȸÁö, Vol. 34, 294~302, 2017 |
2016³â
ÁÖ¿ä È°µ¿³»¿ë |
´Ù¿ë·® Ç×¾Ï Ã³¹æ Àú¼ö°¡ ÇÁ·Î±×·¥ °³¹ß ¹× Àû¿ë |
---|---|
QPS ÁöÁ¤°úÁ¦ "Åõ¾à¿À·ù°³¼±È°µ¿ÆÀ" È°µ¿: - ¸®ÅϾàÇ° °ü¸®¾÷¹« °³¼± - ¾à»ç ó¹æÁßÀç°á°ú Áø·á°úº° °øÁö - °æ±¸¾à ¶óº§¸µ °³¼± |
|
¸¶¾à·ùÅëÇÕ°ü¸® ½Ã½ºÅÛ º¸°í ½Ã¹ü»ç¾÷ ¿Ï·á | |
¾à»ç Á÷¹«¿ª·® °È¸¦ À§ÇÑ Àü¹®ºÐ¾ßº° Áý´ãȸ ½ÃÇà | |
¼ö»ó | ¹èÁ¤È: ¿ì¼öÁ÷¿ø»ó ¼ö»ó |
QI È°µ¿ | ¾à¹«ÆÀ: ´Ù¿ë·® Ç×¾Ïó¹æÀ» Àú¼ö°¡·Î ½º¸¶Æ®ÇÏ°Ô(QI¿µ¿ª Àå·Á»ó) |
¹ßÇ¥ | Kyong Ju Jeong, Go Woon Kim, Hee Kyung Jo, Sung Hyun Chung: [Poster] In silico approach to detect genes involved in the development of T2DM, ACCP 2016 Ji Eun Yoon, Kyong Nam Ye, Jung Tae Kim: [Poster] Evaluation of reducing prescribing -related error through application of computerized IV admixture fluid order program, ACCP 2016 CHEON Young Ju1,2, KIM Jung Tae2, LIM Sung Cil: [Poster] The frequency of out-of-stock and the domestic production percentage of the vaccines, ACCP 2016 Su MI Jang, Min Kyung Lee, Jung Bo Kim, So Hyun Jung, Kyung Ju Jung: [Poster] Evaluation of ward-based pharmacist's interventions and medication counseling in Korea, ACCP 2016 ¹Ú¹ÌÇý, ¿¹°æ³², ±èÁ¤ÅÂ: [Poster] ½Å±â´É ÀúÇÏ È¯ÀÚ¿¡¼ Ç×»ýÁ¦ Åõ¿©¿ë·®ÀÇ ÀûÁ¤¼º Æò°¡, Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ õ¿µÁÖ: [Oral] ±×·ìó¹æ ¾àÇ° Áý°èÇÁ·Î±×·¥ Àû¿ë ÀüÈÄ ¾àÁ¦¾÷¹« °³¼±µµ Æò°¡, Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ |
¿¬±¸ ³í¹® | Á¶ÁöÀ±, ±èÁ¤ÅÂ, ±è½Â¶õ: Nutrition Support Team È°µ¿ÇöȲ Á¶»ç:2016³â vs. 2005³â ºñ±³ ¹× NST¼ö°¡È ÀÌÈÄ È°µ¿ÇöȲ, J Clin Nutr, Vol. 8, No. 2, 98~44, 2016 õ¿µÁÖ, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: ÀÇ·á±â°ü Á¶Á¦½ÇÀÇ Á¤Á¦ Àç»ç¿ëÀ» À§ÇÑ ¹ÝÀÚµ¿ Á¤Á¦ºÐ·ù±â °³¹ß¿¡ ´ëÇÑ ¿¬±¸, º´¿ø¾à»çȸÁö, Vol. 33, No. 3, 248 ~ 255, 2016 À±ÈÖ¿, ±èÁ¤ÅÂ, À¯¿µÈÆ, ¹éÇö¹®, ¼Ûº´Á¤, ±Ç±¤ÀÏ: ¾àÇдëÇп¡¼ ¹®Á¦Áß½ÉÇнÀ¹ýÀÇ È¿°úºÐ¼®- Ãæ³²´ëÇб³ ¾àÇдëÇÐ »ç·Ê¸¦ Áß½ÉÀ¸·Î, ¾àÇÐ³í¹®Áý(Ãæ³²´ë), Vol. 31, 81~88, 2016 ¿¹°æ³², ÀÓ¼º½Ç: ÅëdzÀ» µ¿¹ÝÇÑ °íÇ÷¾Ð ȯÀÚ¿¡¼ ¿ä»ê°¨¼Ò¸¦ À§ÇÑ losartan°ú ´Ù¸¥ ARBs°£ÀÇ ÀÓ»óÀû ÀÇ¹Ì Æò°¡, ´ëÇѾàÇÐȸÁö, 222-225, 2016 ¿ÀÈñ°æ, Àü¼¼Áø, À̼±Èñ µî: Swertisin ameliorates pre-pulse inhibition deficits and cognitive impairment induced by MK-801 in mice. J pasychopharmacol, 31(2):250-259, 2016 |
2015³â
1¿ù | ¿Ü·¡Á¶Á¦½Ç ÀÌÀü(1Ãþ ¡æ ÁöÇÏ 1Ãþ) ¹× º´µ¿¾à±¹ Àç¹èÄ¡ |
---|---|
4¿ù | ¿ø³» Á¶¿µÁ¦ ¾àÇ° »ç¿ë ¹× °ü¸® ¾÷¹« °³¼± |
5¿ù | 2ÁÖ±â ÀÇ·á±â°ü ÀÎÁõ |
6¿ù | ¸Þ¸£½º ´ëÀÀ ºñ»ó ¿î¿µ ½Ç½Ã |
10¿ù | Ç×»ýÁ¦ Èñ¼® ¼ö¾× ÀÚµ¿ Ãßõ ÇÁ·Î±×·¥ Àû¿ë |
¼ö»ó | ¾àÁ¦ºÎ: °æÈñ´ëÇб³ ÁÖü ǥâÀå ¼ö»ó |
QI È°µ¿ | ¿¹°æ³², À±ÁöÀº ¿Ü: ÁÖ»çÁ¦ Èñ¼® ¼ö¾× ó¹æ ´©¶ô ¹× ¿À·ù °¨¼Ò(ÃÖ¿ì¼ö»ó) Á¤°æÁÖ, ±èÁ¤º¸ ¿Ü: º´µ¿ Àü´ã¾à»ç Á¦µµ µµÀÔÀ» ÅëÇÑ ÀÔ¿øȯÀÚÀÇ ¾ÈÀüÇÑ ¾à¹°¿ä¹ý °È(¿ì¼öÆ÷½ºÅÍ»ó) |
¹ßÇ¥ | À̼ø: [Poster] ´Ùºóµµ ¾ç-ÇÑ¹æ º´¿ë ó¹æ ¿¹ºñ¿¬±¸, Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ õ¿µÁÖ, ÀÌÈñÂù, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: [Poster] Influence of the efficacy and adverse effects of dutasteride, ´ëÇѾàÇÐȸ õ¿µÁÖ, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: [Poster] Semi-automatic tablet sorting device (STSD) Development for Improving the efficiency of drug management, ´ëÇѾàÇÐȸ |
¿¬±¸ ³í¹® | õ¿µÁÖ, ¿¹°æ³², ±èÁ¤¿Á, À±ÁöÀº, ¹Ú¹ÌÇý, Á¤°æÁÖ, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: Áö¼ÓÁ¤¸ÆÁÖÀÔ ÇìÆĸ°ÀÇ Ã³¹æ ¹× Åõ¿© ÀÚµ¿È ÇÁ·Î±×·¥ Àû¿ëÀ» ÅëÇÑ ¾÷¹« °³¼± ¿¬±¸, º´¿ø¾à»çȸÁö, Vol. 32, No. 1, 8-20, 2015 ¿¹°æ³², ±è¹ÎÁ¤, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: º¹¾à¼øÀÀµµ ÁõÁøÀ» À§ÇÑ È¯ÀÚ ´ë»ó ¾à¹° »ö伱ȣµµ¿¡ °üÇÑ ±âÃÊ¿¬±¸, ¾àÇÐȸÁö, Vol. 59, No. 1, 23-28, 2015 õ¿µÁÖ, ¹Ú¿ë¼º, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: Á¶±â Áø´Ü ÆÄŲ½¼º´ ȯÀÚ ÃÖÃÊ ¾à¹°ÀÇ À¯È¿¼º ¹× ¾à¹° ³»¼º ±â°£¿¡ ´ëÇÑ Æò°¡, ¾àÇÐȸÁö, Vol. 59, No. 3, 127-134, 2015 õ¿µÁÖ, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: ¹Ì±¹ ½ÄÇ°ÀǾàÇ° ¹Ì½ÂÀÎ µÎŸ½ºÅ׶óÀ̵åÀÇ ±¹³» ³²¼ºÇü Å»¸ðÁõ ¾à¹°¿ä¹ý Àû¿ë¿¡ ´ëÇÑ ÈÄÇâÀû Æò°¡, Çѱ¹ÀÓ»ó¾àÇÐȸ, Vol. 25, No. 3, 171-177, 2015 |
2014³â
1¿ù | ÆÄŲ½¼º´ ¾à¹°±³À°, Åõ¼®È¯ÀÚ ¾à¹°±³À° ½ÃÀÛ |
---|---|
2¿ù | Heparin order program Àû¿ë |
3¿ù | ¿Ü±¹ÀΠȯÀÚ ¿µ¹®º¹¾à¾È³»¹® Á¦°ø |
6¿ù | ¾àÁ¦ ¿µ¿ªÁöÇ¥(ó¹æÁßÀç ¼º°ø·ü) °ü¸® |
¼ö»ó | ¾à¹«ÆÀ: °³¿ø 8Áֳ⠱â³ä ¿ì¼öºÎ¼»ó ¹èÈñ°æ: Board of Pharmacy Specialties (BPS) Board certified Pharmacotherapy Specialist Ãëµæ |
QI È°µ¿ | ¹Ú¹ÌÇý ¿Ü: ÇìÆĸ°À» ¾ÈÀüÇÏ°í Æí¸®ÇÏ°Ô(¿ì¼ö»ó) |
¹ßÇ¥ | ±èÁ¤ÅÂ: Safe management of Anticoagulation drug through Pharmacy intervention, Àڱݼº ±¹Á¦¾àÇÐ ³í´Ü (Áß±¹) õ¿µÁÖ: Áö¼ÓÁ¤¸ÆÁÖÀÔ ÇìÆĸ°ÀÇ Ã³¹æ ¹× Åõ¿© ÇÁ·Î±×·¥ Àû¿ë ¾÷¹« °³¼± ¿¬±¸, Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ õ¿µÁÖ: [Poster] presentation: Evaluation of Beer¡¯s Criteria Drugs prescribed in the Elderly patients of Ambulatory Care Unit, The Pharmaceutical Society of Korea õ¿µÁÖ: [Poster] The Anaylsis of Comparison in Clinical Effectiveness of Unfractiuonated Heparin Computerized System, Àڱݼº ±¹Á¦¾àÇÐ ³í´Ü (Áß±¹) õ¿µÁÖ: [Poster] presentation: Evaluation of Using pattern of the Topical including Steroid in Community of Korean, The Pharmaceutical Society of Korea ¿¹°æ³²: [Poster] A New Suggestion of Compliance Increasing Way in Chronic Disease Patients for Pharmacotherapy, The Korean Society of Apllied Pharmacology À̼ø: [Poster] ÇѾàÀμº °£¼Õ»ó °ü·Ã »ç·Êº¸°í, Çѱ¹º´¿ø¾à»çȸ Ãß°èÇмú´ëȸ |
¿¬±¸ ³í¹® | ±èÁ¾À±, ±èÁø¼÷, Á¤ÁöÇö, ±èÁ¤ÅÂ, À±Çö¿Á, À¯±â¿¬: °¥±Ù ÇÔÀ¯ÅÁÁ¦ÀÇ Ç÷´ç °ÇÏ È¿°ú, º´¿ø¾à»çȸÁö, Vol. 31, No. 6, 1074~1083. 2014 õ¿µÁÖ, ±è¼÷Çö, ±è¿ÁÁÖ, È«¼¼È, ¾çÁø¿í, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: Çѱ¹ ¿Ü·¡Çü ±¹¼Ò¿ë ÇǺΠ¿Ü¿ëÁ¦ÀÇ »ç¿ë ÇöȲ¿¡ ´ëÇÑ ±âÃÊ Æò°¡, ¾àÇÐȸÁö, Vol. 58, No. 6 378~386, 2014 ÀÌÇöÁ¤, ±èÁ¤ÅÂ, À̺´±¸: Á¤¸Æ¿µ¾çÀ» ½ÃÇàÇÑ À§Àå°ü¾Ï ¼ö¼úȯÀÚ¿¡¼ ¿µ¾çÁýÁßÁö¿øÆÀÀÇ ÁßÀçÈ¿°ú, J Clin Nutr, Vol. 6, No. 2, 79~86, 2014 ÀÌ¿Á»ó, õ¿µÁÖ, ¿¹°æ³², À±Èñ¿µ, ±èÁ¤ÅÂ, ÀÌÀ±Á¤, ÀÓ¼º½Ç: Çѱ¹Àû ÀÇÇÐ ±âÁØ¿¡ ±Ù°ÅÇÑ °íÇ÷¾ÐȯÀÚÀÇ Angiotensin ¥± Receptor Blockers¿Í Calcium Channel BlockersÀÇ ¾à¹° Æò°¡, ¾àÇÐȸÁö, Vol. 58, No. 2, 141-149, 2014 À±¼ö¹Ì, ±èÁ¾À±, ±èÁ¤ÅÂ, À¯±â¿¬: ¾àÇдëÇлýÀÇ ÀÇ·á±â°ü ½Ç¹«½Ç½À¿¡¼ Àû¿ëÇÑ ¹®Á¦Áß½ÉÇнÀ¹ý È¿°ú, º´¿ø¾à»çȸÁö, Vol. 31, No. 2, 735-743, 2014 ±èÁö¿¬, ÀÌ¸í±¸, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: Á¦ 2Çü ´ç´¢º´ ȯÀÚ¿¡¼ »ç»óüÁú¿¡ µû¸¥ °æ±¸ Ç÷´ç °ÇÏ¿ä¹ýÀÇ Ä¡·á ¹ÝÀÀ¼º ¹× »ç¿ë ÆÐÅÏ Æò°¡, ¾àÇÐȸÁö, Vol. 58, No. 1, 71-79, 2014 õ¿µÁÖ, ÀÓ¼º½Ç: Beers Criteria ¹× STOPP ±Ù°Å¿¡ ÀÇ°ÅÇÑ Çѱ¹ ³ëÀΠȯÀÚÀÇ Ç×Äݸ°¼ºÁ¦ ¾à¹°¿ä¹ýÀÇ ÀûÀý¼º Æò°¡, ¾àÇÐȸÁö, Vol. 58, No. 5, 328-336, 2014 SJ Park, YH Lee, HK Oh, HE Lee, SY Ko, BS Kim, JH Cheong, CY Shin, JH Ryu: Oleanolic acid attenuates MK-801-induced schizophrenia-like behaviors in mice, Neuropharmacology, Vol.86,49-56, 2014 |
2013³â
7¿ù | °æÈñ´ëÇб³ ¾àÇдëÇаú ¾à´ë 6³âÁ¦ º´¿ø½Ç¹«½Ç½À ±³À°Çù¾à ü°á(À§Å¹) |
---|---|
°Ë»ç¼Ò°³ | °íÇÔ·® ºÐÇÒ °ü¸® ÇÁ·Î±×·¥ ½ÃÇà |
12¿ù | ¾àÁ¦ºÎ ȨÆäÀÌÁö °³¼³ Á¦4ȸ KSHP Àü¹®¾à»ç ÀÚ°Ý Ãëµæ(ÃÑ 1¸í) |
¹ßÇ¥ | ¿ÀÈñ°æ: Kami-ondam-tang, a traditional herbal prescription, attenuates the prepulse inhibition deficits and cognitive impairments induced by MK-801 in mice, The 13th Asian Conference on Clinical Pharmacy ±èÁ¤ÅÂ: Analysis of market size and characteristic of parenteral nutrition formula in Korea, ÀϺ» Á¤¸Æ°æÀå ¿µ¾çÇÐȸ Á¤ÁöÇö, ±èÁ¤ÅÂ, À¯±â¿¬: ¼Ò¾Æ ¾à¹°À¯ÇعÝÀÀ º¸°í »ç·Ê ºÐ¼®, Çѱ¹º´¿ø¾à»çȸÁö, Vol. 30, No. 2, 108 ~ 118, 2013 ±èÁ¤ÅÂ, ±èÁ¾À±, ±è¸íõ, À¯±â¿¬: ÀÓ»ó¾àÇÐ ±³À°¿¡¼ÀÇ ¹®Á¦Áß½ÉÇнÀ ¼ö¾÷ ¹æ¹ý Àû¿ë Æò°¡, Çѱ¹ÀÓ»ó¾àÇÐȸÁö, Vol. 23, No. 1. 2013 ÀÌ¿Á»ó, ±èÁ¤ÅÂ, õ¿µÁÖ, ÀÓ¼º½Ç: Çѱ¹º´¿ø¾à»çÀÇ Çص¶Á¦¿¡ °üÇÑ Á¤º¸´É·Â Æò°¡ ¹× ±³À°ÀÇ Çʿ伺, Çѱ¹ÀÓ»ó¾àÇÐȸÁö, Vol. 23, No. 1. 2013 õºÎ¼ø, ±èÁ¾À±, ±èÁ¤ÅÂ, ±¸º»±â, À¯±â¿¬: ¿ÍÆĸ°°ú »ý¾àÁ¦ÀÇ ¾à¹° »óÈ£ÀÛ¿ë ¸®ºä, º´¿ø¾à»çȸÁö, Vol. 30, No. 5, 450~470, 2013 Â÷À±¿µ, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: ÀÔ¿øÃʱ⠿µ¾çºÒ·® ȯÀÚÀÇ TPN Áöħ¿¡ µû¸¥ ¿µ¾ç°³¼± Æò°¡, Çѱ¹ÀÓ»ó¾àÇÐȸÁö, Vol. 23, No. 4, 365~372, 2013 À̹̼ö, ±èÀºÁø, À±ÁöÀº, õ¿µÁÖ, ¿¹°æ³², Á¤°æÁÖ, ±èÁ¤ÅÂ: »êÁ¦ Á¶Á¦ ¾÷¹«ÀÇ °³¼± È°µ¿, º´¿ø¾à»çȸÁö, Vol. 30, No. 6, 531~548, 2013 Oh HK, Park SJ, Bae SG, Kim MJ, Jang JH, Ahn YJ, Woo H, Kwon G, Ryu JH : Kami-ondam-tang, a traditional herbal prescription, attenuates the prepulse inhibition deficits and cognitive impairments induced by MK-801 in mice, J Ethnopharmacol. 2013 Mar 27;146(2):600-7 |
2012³â
3¿ù | ¿Ü·¡Á¶Á¦½Ç ÀÌÀü (ÁöÇÏ 1Ãþ ¡æ 1Ãþ) Á¦ 3ȸ º¸°Ç±³À°»ç 3±Þ Ãëµæ, Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø (ÃÑ 7¸í) |
---|---|
7¿ù | ¾àÁ¦ºÎ ´º½º·¹ÅÍ È¨ÆäÀÌÁö °ÔÀç |
11¿ù | Á¦3ȸ KSHP Àü¹®¾à»ç ÀÚ°Ý Ãëµæ(ÃÑ 1¸í) |
QI È°µ¿ | À±ÁöÀº ¿Ü: ¾àº¹¿ë¹ýÀ» ´Ù±¹¾î·Î ¾Ë·Áµå¸³´Ï´Ù. (ÃÖ¿ì¼ö»ó ¼ö»ó) |
¹ßÇ¥ | À̹̼ö: Improvement activity for dispensing and intervention prescriptions of powder form drugs, 47th ASHP Midyear Clinical Meeting |
¿¬±¸ ³í¹® | ÀÌ¿Á»ó, õ¿µÁÖ, ±èÁ¤ÅÂ, ÀÓ¼º½Ç: ÀÀ±Þ½Ç ³»¿øÇÑ ÀÚ»ì ½Ãµµ ȯÀÚÀÇ ÀÚ»ì½Ãµµ¿ë ¾à¹° ¹× Çص¶Á¦ »ç¿ë ÇöȲ¿¡ ´ëÇÑ Æò°¡, Çѱ¹ÀÓ»ó¾àÇÐȸÁö, Vol. 22, No. 4. 2012 ¹èÁ¤È, ±èÁ¤ÅÂ, Á¤¼ºÇö: °¨ÃÊ°¡ Æ÷ÇÔµÈ ÇÑ¾à º¹¿ë ½Ã Ç÷Áß Æ÷Ÿ½· ¼öÄ¡ÀÇ ÀúÇÏ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ, Çѱ¹ÀÓ»ó¾àÇÐȸÁö, Vol. 22, No. 2. 2012 ¿¹°æ³², ±èÁ¤ÅÂ, À̼÷Çâ: °ü»óµ¿¸Æ ¾à¹° ¿ëÃâ ½ºÅÙÆ® »ðÀÔ ÈÄ Ç×Ç÷¼ÒÆÇÁ¦Á¦ 3Á¦¿ä¹ý°ú 2Á¦¿ä¹ýÀÇ ÀÓ»óÀû È¿°ú ºñ±³, Çѱ¹ÀÓ»ó¾àÇÐȸÁö, Vol. 22, No. 2. 2012 Hai-Dan Yuan, Jung Tae Kim, Sung Hyun Chung: Pectinase-Processed Ginseng Radix (GINST) Ameliorates Hyperglycemia and Hyperlipidemia in High Fat Diet-Fed ICR Mice, Biomol Ther 20(2), 220-225 (2012) Hai-Dan Yuan, Jung Tae Kim, Sung Hoon Kim, Sung Hyun Chung: Ginseng and Diabetes: The Evidences from In Vitro, Animal and Human Studies, J. Ginseng Res. Vol. 36, No. 1, 27-39(2012) |
2011³â
3¿ù | ÀÇ·á±â°ü ÀÎÁõÆò°¡ ¼ö°Ë ¹× ÀÎÁõÀÇ·á±â°ü ȹµæ |
---|---|
11¿ù | Á¦2ȸ KSHP Àü¹®¾à»ç ÀÚ°Ý Ãëµæ(ÃÑ 1¸í) |
¼ö»ó | ±èÁ¤Å ¿Ü: 2011³â °æ±âµµ¾à»çȸ ÇмúÁ¦ ¿ì¼ö³í¹®»ó (Ưº°»ó) |
¹ßÇ¥ | ±èÁ¤ÅÂ: Oncology Pharmacist's role, risk management on using Chemotherapy Order Program, Àڱݼº ±¹Á¦¾àÇÐ ³í´Ü(Áß±¹, ºÏ°æ) |
¿¬±¸ ³í¹® | ¿À´ÙÀº, À̹̼ö, ÀÌÀ±´ö, ¿¹°æ³², ±èÁ¤ÅÂ: ¹Ì¹Ý³³¾à °¨¼Ò¸¦ À§ÇÑ ¾àÇ° ¹Ý³³ ¾÷¹« °³¼± È°µ¿, º´¿ø¾à»çȸÁö, Vol. 28, No. 4, 364~371 (2011) Ji Hae Kim, Min Jung Chang, Hye Duck Choi, Yeo-Kyu Youn, Jung Tae Kim, Jung Mi Oh, Wan Gyoon Shin: Protective Effects of Haematococcus Astaxanthin on Oxidative Stress in Healthy Smokers, J Med Food 14 (0) Jong-Hyun Han, Wonil Koh, Hyo-Jung Lee, Hyo-Jeong Lee, Eun-Ok Lee, Soo Jin Lee, Jae-Ho Khil, Jung Tae Kim, Soo-Jin Jeong, Sung-Hoon Kim: Analgesic and anti-inflammatory effects of ethyl acetate fraction of Polygonum cuspidatum in experimental animals, Immunopharmacology and Immunotoxicology, 2011, 1-5, Early Online ½É°è½Ä, ±èÁ¤ÅÂ: ¼Ò¾Æû¼Ò³â±â Ư¹ß¼º ¼ºÁ¶¼÷ÁõÀÇ Ä¡·á, ´ëÇÑÀÇ»çÇùȸÁö, 2011, September; 54(9): 953-956 |
2010³â
3¿ù | ¾àÁ¦ºÎ Á¶Á÷ °³Æí (3ÆÀ 6ÆÄÆ®) |
---|---|
4¿ù | Á¶Á¦½Ç ¸®¸ðµ¨¸µ ½Ç½Ã |
11¿ù | Á¦1ȸ KSHP Àü¹®¾à»ç ÀÚ°Ý Ãëµæ(ÃÑ 4¸í) |
¼ö»ó | ±èÁ¤ÅÂ: 2010³â ´ëÇѾà»çȸ ǥâ ±èÁ¤ÅÂ: 2010³â º¸°Çº¹ÁöºÎÀå°ü ǥâ |
QI È°µ¿ | ¿À´ÙÀº ¿Ü: ¹Ì¹Ý³³¾à °¨¼Ò¸¦ À§ÇÑ ¹Ý³³¾à process °³¼± È°µ¿ (ÀαâÆ÷½ºÅÍ»ó ¼ö»ó) |
¹ßÇ¥ | µµÀ±Á¤: Parenteral Nutrition Support and NST Management in ICU Patients, 32nd ESPEN congress (Clinical Nutrition & Metabolism International Congress) ¿¹°æ³²: Effect of triple antiplatelet therapy after drug-eluting stent implantation, 45th ASHP Midyear Clinical Meeting |
¿¬±¸ ³í¹® | µµÀ±Á¤, Á¶¹Ì¶õ, ±è¸íõ, ±èÁ¤ÅÂ, À̼÷Çâ: ÁßȯÀÚ½Ç Àç¿øȯÀÚ Áö¿ø°ú ¿µ¾çÁýÁßÁö¿øÆÀÈ°µ¿¿¡ °üÇÑ ºñ±³ºÐ¼® ¿¬±¸, Çѱ¹Á¤¸Æ°æÀ念¾çÇÐȸÁö, Vol. 3, No.1. 2010 |
2009³â
10¿ù | ¾ß°£ ¾à±¹ ¾à»ç 2ÀÎ ¾÷¹« ½ÃÀÛ(¾ß°£ Àü´ã ¾à»ç 6¸í) |
---|---|
¹ßÇ¥ | ±¸¹ÌÀÚ: Cost-analysis of stroke patients with the integrated western and oriental medical treatment in South Korea, 44th ASHP Midyear Clinical Meeting ±èÀºÁ¤: Meta-analysis of Monotherapy and Combination therapy of Methotrexate and TNF inhibitors in Rheumatoid Arthritis, 44th ASHP Midyear Clinical Meeting |
¿¬±¸ ³í¹® | ±èÁ¤ÅÂ, Á¤¼ºÇö: ÀÏȸ¿ë ¾à¹° ÁÖÀԱⱸ¸¦ ÀÌ¿ëÇÑ 5-FluorouracilÀÇ Áö¼ÓÁÖÀÔÈ¿°ú¿Í ¿ë±â ³» ¾ÈÁ¤¼º Æò°¡, Çѱ¹ÀÓ»ó¾àÇÐȸÁö, Vol. 19, No.1. 2009 |
2008³â
10¿ù | Ä¡°úÁ¶Á¦½Ç ÄÚµå ½Å¼³ |
---|---|
QI È°µ¿ | À̼ø ¿Ü: Åð¿øÇѾà Åõ¾à´ë±â½Ã°£´ÜÃà (¿ì¼öÆ÷½ºÅÍ»ó ¼ö»ó) |
¹ßÇ¥ | ±èÁ¤ÅÂ: Determination of Flow Rate and Stability of 5-Fluorouracil in Disposal Infusion Device, Anapa,43rd ASHP Midyear Clinical Meeting ±èÁ¤ÅÂ: Role of Pharmacist on NST, Ãß°èÇмú´ëȸ ½ÉÆ÷Áö¿ò |
2007³â
3¿ù | NST À§¿øȸ ¹ßÁ· ¹× NST ÀÚ¹® ¾à»ç ¾÷¹« ½ÃÀÛ |
---|---|
6¿ù | ¾à¹°ÀÌ»ó¹ÝÀÀ¸ð´ÏÅ͸µ¾÷¹«½ÃÀÛ ½ÅÀåÀ̽ÄȯÀÚº¹¾à»ó´ã½ÃÀÛ |
7¿ù | º´¿ø ½ÅÀÓÆò°¡ ÇöÁöÁ¶»ç (1Â÷ ³âµµ) |
8¿ù | ÈíÀÔ±â ȯÀÚ º¹¾à»ó´ã ½ÃÀÛ |
10¿ù | 2007³â ÀÇ·á±â°üÆò°¡ ¼ö°Ë |
¹ßÇ¥ | ±èÁ¤º¸: Impact of pharmacist intervention on the incidence of hand-foot syndrome of patients taking capecitabine, Çѱ¹º´¿ø¾à»çȸ Á¦ 27ȸ Ãß°èÇмú´ëȸ ±èÁ¤ÅÂ: The present status of NST in Korea, Á¦6ȸ ÇÑÀÏ ÁÖ»çÁ¦ ÀÓ»óÁ¤º¸½ÉÆ÷Áö¿ò |
¿¬±¸ ³í¹® | ±èÁ¤ÅÂ, ÀÌÁ¦È¯, ½ÅÇöÅÃ: Ç×¾ÏÈÇпä¹ý ó¹æÀü»ê ½Ã½ºÅÛ¿¡ ÀÇÇÑ Ã³¹æ Á¤È®µµ¿¡ °üÇÑ ¿¬±¸, Çѱ¹ÀÓ»ó¾àÇÐȸÁö, Vol. 17, No.1. 2007 ¹èÁ¤È, ±è»õ·Ð, Á¤°æÁÖ, ³²ÁöÈñ, ±èÁ¤ÅÂ: ¾ç.Çѹæ ÇùÁø¿¡¼ °æÈñ´ëÇб³ µ¿¼½ÅÀÇÇк´¿øÀÇ ÇÑ¹æ ¾àÁ¦ EMR ÇÁ·Î±×·¥ °³¹ß, º´¿ø¾à»çȸÁö, Vol. 24, No. 2, 151~154(2007) |
2006³â
6¿ù | µ¿¼½ÅÀÇÇк´¿ø °³¿ø°ú ÇÔ²² ¾àÁ¦ºÎ(2ÆÀ 3ÆÄÆ®) ±¸¼º °³¿ø ÀηÂ: ÆÀÀå 1¸í, ÆÄÆ®Àå 1¸í, ¾à»ç 12¸í, ÇѾà»ç 7¸í, ¾ß°£ Àü´ã ¾à»ç 3¸í ÆÄÆ®Àå 1¸í, ¾à»ç 12¸í, ÇѾà»ç 7¸í, ¾ß°£ Àü´ã ¾à»ç 3¸í Çѹæó¹æÁý ¹ß°£ |
---|---|
7¿ù | Ç×ÀÀ°í ¾à¹° º¹¾à »ó´ã ½ÃÀÛ Åð¿ø ȯÀÚ º¹¾à »ó´ã ½ÃÀÛ |
8¿ù | Oncology º´µ¿ ¾à»ç ¾÷¹« ½ÃÀÛ |
¹ßÇ¥ | ±èÁ¤º¸: °æÈñ´ëÇб³ µ¿¼½ÅÀÇÇк´¿ø ÅëÇÕ ¾Ï¼¾ÅÍ ³» ÀÓ»ó¾à»çÀÇ ¿ªÇÒ, Çѱ¹º´¿ø¾à»çȸ Á¦ 26ȸ Ãß°èÇмú´ëȸ ¿¹°æ³²: Ÿ°úÀÇ·Ú¸¦ ÅëÇÑ ÀÓ»ó¾àÁ¦¼ºñ½º ÇÁ·Î±×·¥ °³¹ß, Çѱ¹º´¿ø¾à»çȸ Á¦ 26ȸ Ãß°èÇмú´ëȸ À̹̼ö: ERP systemÀ» ÅëÇÑ Á¶Á¦½ÇÁ¦Á¦ÀÇ ÀûÁ¤Àç°í°ü¸® ¹× ¾÷¹« Ç¥ÁØÈ£ ÇÁ·Î±×·¥ ±¸Ãâ¿¡ ´ëÇÑ »ç·Êº¸°í, Çѱ¹º´¿ø¾à»çȸ Á¦ 26ȸ Ãß°èÇмú´ëȸ õ¿µÁÖ: TPN ¾÷¹« ÇÁ·Î±×·¥ °³¹ß°ú ¿î¿ë¿¡¼ÀÇ ¾à»çÀÇ ¿ªÇÒ Á¶¸í, Çѱ¹º´¿ø¾à»çȸ Á¦ 26ȸ Ãß°èÇмú´ëȸ |
¿¬±¸ ³í¹® | ¹ÚÀ±Èñ, ±è¹Î¼±, ±èÁ¤ÅÂ, ±èÀ翬, ½ÅÇý¿µ: UDS (Unit Dose System)Á¶Á¦ ÈÄ ¹ß»ýÇÏ´Â Æó±âÀ² °¨¼Ò¸¦ À§ÇÑ °³¼±È°µ¿, º´¿ø¾à»çȸÁö, Vol. 23, No. 4, 304~309(2006) |